AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Significant Growth in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totaling 23,366 shares, an increase of 76.3% from the December 31st total of 13,256 shares. Based on an average daily trading volume, of 28,413 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.6% of the company’s stock are sold short. Currently, 0.6% of the company’s stock are sold short. Based on an average daily trading volume, of 28,413 shares, the days-to-cover ratio is presently 0.8 days.

AquaBounty Technologies Stock Down 5.2%

AQB stock opened at $0.91 on Friday. The stock’s 50 day moving average is $0.95 and its two-hundred day moving average is $1.12. AquaBounty Technologies has a 52-week low of $0.50 and a 52-week high of $2.95. The company has a market capitalization of $3.53 million, a PE ratio of -1.10 and a beta of 1.24.

AquaBounty Technologies (NASDAQ:AQB) last released its quarterly earnings results on Tuesday, October 28th. The company reported ($0.36) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.62) by $0.26.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP bought a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies as of its most recent SEC filing. Institutional investors and hedge funds own 8.92% of the company’s stock.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.